ORBIMED ADVISORS LLC Insider Trading for April 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ORBIMED ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of ORBIMED ADVISORS LLC for April 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 26 2021 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 3,605,386 | 0 | 0 | |
| Apr 26 2021 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 171,895 | 0 | 0 | |
| Apr 26 2021 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 3,777,281 | 0 | 4,012,281 | 235 K to 4 M (+1,607.35 %) |
| Apr 23 2021 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 17.00 | 235,000 | 3,995,000 | 235,000 | 0 to 235 K |
| Apr 23 2021 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 17.00 | 235,000 | 3,995,000 | 235,000 | 0 to 235 K |
| Apr 22 2021 | SYBX | SYNLOGIC, INC. | ORBIMED ADVISORS LLC | Director | Grant | A | 3.00 | 1,666,666 | 4,999,998 | 3,696,662 | 2 M to 3.7 M (+82.10 %) |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 68,978 | 0 | 0 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 130,924 | 0 | 0 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 328,907 | 0 | 0 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 920,484 | 0 | 0 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 806,752 | 0 | 0 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 2,257,785 | 0 | 0 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 680,766 | 0 | 0 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 1,905,201 | 0 | 0 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | ORBIMED ADVISORS LLC | Director | Option Exercise | A | 0.00 | 1,430,103 | 0 | 1,430,103 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | ORBIMED ADVISORS LLC | Director | Option Exercise | A | 0.00 | 8,938,148 | 0 | 8,938,148 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 130,924 | 0 | 130,924 | 0 to 130.9 K |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 5,083,470 | 0 | 5,083,470 | 0 to 5.1 M |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | ORBIMED ADVISORS LLC | Director | Buy | P | 16.00 | 48,400 | 774,400 | 117,378 | 69 K to 117.4 K (+70.17 %) |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | ORBIMED ADVISORS LLC | Director | Buy | P | 16.00 | 375,000 | 6,000,000 | 2,191,425 | 1.8 M to 2.2 M (+20.64 %) |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 68,978 | 0 | 68,978 | 0 to 69 K |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,816,425 | 0 | 1,816,425 | 0 to 1.8 M |